Bruker Debt to Equity Ratio 2010-2023 | BRKR
Current and historical debt to equity ratio values for Bruker (BRKR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Bruker debt/equity for the three months ending December 31, 2023 was 0.83.
| Bruker Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2023-12-31 |
$2.86B |
$1.40B |
2.05 |
| 2023-09-30 |
$2.59B |
$1.23B |
2.11 |
| 2023-06-30 |
$2.61B |
$1.25B |
2.08 |
| 2023-03-31 |
$2.57B |
$1.20B |
2.14 |
| 2022-12-31 |
$2.49B |
$1.13B |
2.21 |
| 2022-09-30 |
$2.39B |
$0.95B |
2.52 |
| 2022-06-30 |
$2.40B |
$0.98B |
2.44 |
| 2022-03-31 |
$2.52B |
$1.03B |
2.44 |
| 2021-12-31 |
$2.57B |
$1.09B |
2.37 |
| 2021-09-30 |
$2.04B |
$1.09B |
1.87 |
| 2021-06-30 |
$2.07B |
$1.02B |
2.04 |
| 2021-03-31 |
$2.05B |
$0.98B |
2.09 |
| 2020-12-31 |
$2.08B |
$0.97B |
2.13 |
| 2020-09-30 |
$1.92B |
$0.96B |
1.99 |
| 2020-06-30 |
$2.04B |
$0.91B |
2.25 |
| 2020-03-31 |
$2.04B |
$0.93B |
2.20 |
| 2019-12-31 |
$1.85B |
$0.92B |
2.02 |
| 2019-09-30 |
$1.50B |
$0.86B |
1.75 |
| 2019-06-30 |
$1.48B |
$0.87B |
1.70 |
| 2019-03-31 |
$1.32B |
$0.92B |
1.43 |
| 2018-12-31 |
$1.22B |
$0.91B |
1.35 |
| 2018-09-30 |
$1.06B |
$0.83B |
1.29 |
| 2018-06-30 |
$1.02B |
$0.79B |
1.30 |
| 2018-03-31 |
$1.04B |
$0.79B |
1.32 |
| 2017-12-31 |
$1.22B |
$0.73B |
1.66 |
| 2017-09-30 |
$1.22B |
$0.74B |
1.65 |
| 2017-06-30 |
$1.15B |
$0.76B |
1.51 |
| 2017-03-31 |
$1.11B |
$0.73B |
1.52 |
| 2016-12-31 |
$1.12B |
$0.69B |
1.61 |
| 2016-09-30 |
$1.10B |
$0.70B |
1.57 |
| 2016-06-30 |
$1.05B |
$0.67B |
1.57 |
| 2016-03-31 |
$1.03B |
$0.71B |
1.45 |
| 2015-12-31 |
$1.00B |
$0.73B |
1.36 |
| 2015-09-30 |
$1.08B |
$0.77B |
1.40 |
| 2015-06-30 |
$1.05B |
$0.77B |
1.37 |
| 2015-03-31 |
$1.05B |
$0.72B |
1.46 |
| 2014-12-31 |
$1.09B |
$0.77B |
1.42 |
| 2014-09-30 |
$1.10B |
$0.81B |
1.35 |
| 2014-06-30 |
$1.12B |
$0.89B |
1.26 |
| 2014-03-31 |
$1.16B |
$0.87B |
1.34 |
| 2013-12-31 |
$1.14B |
$0.85B |
1.34 |
| 2013-09-30 |
$1.16B |
$0.78B |
1.48 |
| 2013-06-30 |
$1.08B |
$0.72B |
1.49 |
| 2013-03-31 |
$1.12B |
$0.69B |
1.62 |
| 2012-12-31 |
$1.15B |
$0.71B |
1.62 |
| 2012-09-30 |
$1.10B |
$0.70B |
1.59 |
| 2012-06-30 |
$1.11B |
$0.64B |
1.73 |
| 2012-03-31 |
$1.14B |
$0.66B |
1.72 |
| 2011-12-31 |
$1.09B |
$0.63B |
1.74 |
| 2011-09-30 |
$1.07B |
$0.60B |
1.77 |
| 2011-06-30 |
$1.07B |
$0.63B |
1.70 |
| 2011-03-31 |
$1.05B |
$0.57B |
1.84 |
| 2010-12-31 |
$1.02B |
$0.53B |
1.94 |
| 2010-09-30 |
$0.78B |
$0.49B |
1.59 |
| 2010-06-30 |
$0.73B |
$0.41B |
1.76 |
| 2010-03-31 |
$0.74B |
$0.42B |
1.78 |
| 2009-12-31 |
$0.75B |
$0.42B |
1.80 |
| 2009-09-30 |
$0.75B |
$0.37B |
2.01 |
| 2009-06-30 |
$0.75B |
$0.34B |
2.23 |
| 2009-03-31 |
$0.76B |
$0.30B |
2.56 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$10.705B |
$2.965B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
